Collaborative Research Development Grant

Collaborative Research Development Grant

Status: ACTIVE
Funder: Ovarian Cancer Research Fund Alliance
Amount: Up to US $900,000
Last Updated: February 16, 2026

Summary

The Collaborative Research Development Grant from the Ovarian Cancer Research Fund Alliance aims to support innovative research projects focused on ovarian and related gynecologic cancers. Funding of up to $300,000 per year for three years is available for interdisciplinary teams of investigators. The grant encourages creative and original applications that promise advancements in cancer detection, prevention, and treatment. This initiative fosters collaboration among institutions and welcomes international applicants to enhance research efforts in this critical area.

Overview

Our Mission Ovarian Cancer Research Alliance is dedicated to curing ovarian cancer while improving treatments by advancing innovative science, promoting preventive measures, and advocating for, educating and supporting anyone affected by gynecologic cancers to ensure the best possible care and outcomes. Collaborative Research Development Grant The purpose of this grantmaking program is to provide funds for ovarian cancer and/or related gynecologic cancers research projects that may involve several investigators within one institution or collaborations between groups in multiple institutions. Interdisciplinary collaborations are encouraged. Funding Support of up to $300,000USD annually for three years ($900,000USD total) will be granted to the institution(s) in which the recipients will conduct the research.

Eligibility

You can learn more about this opportunity by visiting the funder's website. The Principal Investigator (one Principal Investigator must be selected) and other investigators must have full-time faculty appointments in a school of medicine or public health or recognized non-profit scientific research facility. At least one key investigator must be a physician with expertise on ovarian cancer.International collaborations are welcome.The selection committee will consider most favorably applications that are creative, original, and hold the most promise in the areas of screening and early detection, etiology and prevention, molecular therapeutics, cancer biology and genetics. Submissions that focus on health services research, quality of life, and epidemiology are also encouraged. Proposed projects should focus on ovarian cancers and/or related gynecologic cancers.The primary review criteria will be the likelihood that the investigators can leverage this funding to establish a research team capable of performing high-impact research and competing successfully for additional funding.International applicants are welcome to apply.Each applicant may submit only one LOI per grant cycle.Additionally, grant recipients can only have one OCRA grant active at a time, if the grant recipient already has an active OCRA grant, the current grant must end before the CRDG may begin.Educational and not-for-profit organizations from anywhere in the world are welcome to apply for OCRA grants.

Ineligibility

Principal Investigator should not currently be in a training program.At this time, OCRA does not fund for-profit entities.Tuition and fees are not an allowable cost on OCRA grants.